Free Newsletter
New primate model for Huntington’s will help researchers
In a first, researchers have developed a primate model for Huntington's disease, eliciting harsh criticism from animal rights experts even as it paves the way for future primate models for a host of degenerative brain disorders. Five rhesus macaque monkeys now produce the rogue protein that leads to Huntington's. And the researchers say the work should help significantly advance work on a cure.
Mice have been used in neurodegenerative research, but don't demonstrate the same kind of symptoms that scientists look for. With the engineered monkeys, researchers will be able to get a much better understanding of the disease and better ways it can be treated in humans.
- read the story from New Scientist
Related Articles:
Cells prompted to "eat" Huntington proteins
Mayo researchers find trigger for Huntington's
Huntington's study reveals insights on genetic testing
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




